RAD51 expression in breast tumors was positively correlated with E2F1 expression and negatively correlated with TODRA (Table 1), indicating that E2F1 indeed regulates the bidirectional promoter in vivo in the malignant state, in the same manner we observed in cell lines. Here, RAD51 is linked to breast neoplasm.